Business Description
Founded in 2005 and based in Calabasas, California, NeOnc Technologies Holdings is a medical research company working to create new treatments for brain cancer. The company is advancing two experimental therapies through clinical trials ? NEO100 and NEO212 ? both designed to target tumors in the brain, including aggressive forms such as glioblastoma and meningioma. NEO212 is taken by mouth and combines two active compounds to improve treatment effectiveness.
